Aemetis (NASDAQ:AMTX) Stock Price Passes Below 200 Day Moving Average – Time to Sell?

Aemetis, Inc. (NASDAQ:AMTX) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.72 and traded as low as $1.65. Aemetis shares last traded at $1.72, with a volume of 726,310 shares.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. StockNews.com raised Aemetis to a “sell” rating in a research note on Wednesday, February 5th. HC Wainwright reissued a “buy” rating and issued a $28.00 price target on shares of Aemetis in a research note on Monday, December 23rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $14.56.

Aemetis Stock Performance

The company has a 50 day simple moving average of $2.29 and a two-hundred day simple moving average of $2.70. The company has a market cap of $89.01 million, a PE ratio of -0.77 and a beta of 1.48.

Hedge Funds Weigh In On Aemetis

Several institutional investors and hedge funds have recently bought and sold shares of the business. ProShare Advisors LLC purchased a new position in Aemetis during the 4th quarter valued at about $27,000. Bank of America Corp DE grew its stake in Aemetis by 37.8% during the 4th quarter. Bank of America Corp DE now owns 56,675 shares of the specialty chemicals company’s stock valued at $152,000 after acquiring an additional 15,533 shares in the last quarter. Jane Street Group LLC grew its stake in Aemetis by 1,130.0% during the 4th quarter. Jane Street Group LLC now owns 374,016 shares of the specialty chemicals company’s stock valued at $1,006,000 after acquiring an additional 343,609 shares in the last quarter. Northern Trust Corp grew its stake in Aemetis by 3.7% during the 4th quarter. Northern Trust Corp now owns 297,023 shares of the specialty chemicals company’s stock valued at $799,000 after acquiring an additional 10,658 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC purchased a new position in Aemetis during the 4th quarter valued at about $227,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.